The value of Gadoxetic Acid as a hepatobiliary-specific contrast agent in Magnetic Resonance Imaging in the assessment of focal liver lesions

Not Applicable

• Conditions: iver; liver neoplasms; focal nodular hyperplasia of the liver; A03.620; C04.588.274.623; C06.552.270

• Registration Number: RBR-5n2x5v
• Lead Sponsor: Faculdade de Ciências Médicas da Universidade Estadual de Campinas

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-02-13
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Data analysis completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Magnetic resonance imaging of the abdomen using gadoxetic acid as a contrast agent in the assessment of focal liver lesions that had already been identified in previous examinations (ultrasound, computed tomography or magnetic resonance with conventional gadolinium), but which still remained undetermined, requiring complementation diagnostics, performed at the HC of FCM / UNICAMP, from January 2015 to December 2018

Exclusion Criteria

Absence of definitive diagnostic criteria for focal liver lesions; radioablation and / or chemoembolization prior to the lesion to be analyzed; examination artifacts preventing adequate characterization of the lesion to be analyzed; absence of detection of the focal lesion in the MR examination; age under 18 and over 78

Study & Design

• Study Type: Intervention
• Study Design: Not specified